
Latest Articles
Dupilumab in Pediatric EoE: Phase 3 KIDS Study Results
This poster presentation evaluates the efficacy of dupilumab in treating eosinophilic esophagitis (EoE) in patients weighing ≥15 kg at baseline from the Phase 3 KIDS study.
Improving Quality of Life in Patients with Uncontrolled Atopic Dermatitis (AD): Tools for Timely Identification and Treatment

Unseen Burdens: How Cumulative Life Course Impairment (CLCI) Affects Patients with Moderate-to-Severe Atopic Dermatitis (AD)
The Hidden Impact of Cumulative Life Course Impairment (CLCI) in Dermatology: An Overview
Nirsevimab FAQs
RWE data on Nirsevimab and RSV preF vaccine
Real‑world evidence (RWE) provides valuable insights into the effectiveness, safety, and use of RSV preventive strategies beyond clinical trials. This data support informed decision‑making and optimize the implementation of RSV prevention strategies in real‑world settings
Ensuring overall RSV prevention in every individual Dr. Alia Podcast
Factors Associated with Development of Atopic Comorbidities in AD
The soundbite recording captures Dr. Paller's discussion on factors that contribute to the development of atopic comorbidities in patients with atopic dermatitis. The presentation examines the relationship between AD and associated atopic conditions.